We have established and organized the largest single-center MPN-specific tissue bank and clinical database in the world. Tissue and blood samples from patients with myeloproliferative neoplasias are crucial for developing more effective treatments for MPN.
Samples collected before and during treatment can be used to understand prognosis and response to therapy. In addition, patient samples can be used for translational research to explore the underlying biology and pathophysiology of MPN or to test new medications specifically for MPN.
Currently, the tissue bank contains samples from more than 1,500 patients with an accompanying clinical database with corresponding clinical information.